newsfilter
← Latest News
GlobeNewswire·

Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

CHICAGO and TORONTO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care